PM chairs key Covid meet as festival season starts

New Delhi: Amid concerns about resurgence of Covid-19 cases in some cities in the wake of the festival seasonPrime Minister Narendra Modi on Friday stressed on the need for constant genome sequencing to monitor emergence of mutants.

PM Modi was chairing a high-level meeting to take stock of the Covid-19 situation in the country as well as the vaccination status.

INSACOG now consists of 28 labs across the country with the lab network linked with a hospital network for clinical correlation. Besides, sewage sampling is also being done for genomic surveillance, officials apprised the PM during the meeting. The PM also underlined the need to augment healthcare infrastructure and asked states to maintain buffer stock of medicines in every district. He also reviewed production, supply and pipeline of vaccines for the next few months.

During the meeting, PM Modi discussed that across the world, there are countries where the number of active Covid cases continues to remain high. In India too, the figures from states like Maharashtra and Kerala, indicate that there can be no room for complacency, officials pointed out.

The principal secretary to PM, cabinet secretary, principal scientific adviser, health secretary and member health NITI Aayog were among the officials were present in the meeting. Around 39 districts have weekly positivity above 10%. However, the overall weekly positivity has stabilised at below 3% for the tenth consecutive week.

  • Related Posts

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre